Skip to content
Monday, January 12, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Suspect charged in arson that damaged Jackson, Mississippi’s only synagogue January 11, 2026
  • Celebrate Early and Often January 11, 2026
  • What Will Khamenei Do With His $94 Billion? January 9, 2026
  • After Australian literary festival drops Palestinian activist, citing Bondi massacre, dozens boycott in solidarity January 9, 2026
  • From pop stars to tefillin pop-ups, Oct. 7 changed how Israel’s ‘somewhat observant’ practice Judaism January 9, 2026
  • Eli Sharabi’s Unflinching Account of Captivity, Loss and Survival January 9, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.